Literature DB >> 12619924

Autosomal dominant gnathodiaphyseal dysplasia maps to chromosome 11p14.3-15.1.

Satoshi Tsutsumi1, Nobuyuki Kamata, Yutaka Maruoka, Miki Ando, Osamu Tezuka, Shoji Enomoto, Ken Omura, Masaru Nagayama, Eiji Kudo, Maki Moritani, Takashi Yamaoka, Mitsuo Itakura.   

Abstract

Gnathodiaphyseal dysplasia (GDD) is a syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of jawbones. Although some cases of this syndrome exist in families with autosomal dominant inheritance, the underlying gene has never been identified. We analyzed a large four-generation family with GDD by linkage analysis using genomic DNA from nine affected and six nonaffected family members. A genome-wide search using a set of highly polymorphic microsatellite markers showed evidence for linkage to chromosome 11p14.3-15.1. Two-point linkage analysis of microsatellite markers spanning this locus resulted in a maximum logarithm of odds (LOD) score of 2.70 with a recombination fraction (theta) of 0 at D11S1755, D11S1759, and D11S915, and a maximum LOD score of 3.01 at D11S4114 was obtained in multipoint linkage analysis. Haplotype analysis detected no recombination between GDD and six closely linked markers (D11S928, D11S1755, D11S4114, D11S1759, D11S915, and D11S929) and established the candidate interval of 8.7 cM on chromosome 11p for GDD. Although GDD has been considered to be a variation of osteogenesis imperfecta (MIM 166260), our results indicate that this syndrome is a new and distinct disease entity from other systemic bone diseases. Furthermore, these genetic markers are useful for presymptomatic diagnosis of GDD in some families and for identification of the GDD gene.

Entities:  

Mesh:

Year:  2003        PMID: 12619924     DOI: 10.1359/jbmr.2003.18.3.413

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Gnathodiaphyseal dysplasia.

Authors:  T E Herman; M J Siegel; K Sargar
Journal:  J Perinatol       Date:  2014-05       Impact factor: 2.521

Review 2.  Fibro-osseous lesions of the craniofacial skeleton: an update.

Authors:  Samir K El-Mofty
Journal:  Head Neck Pathol       Date:  2014-11-20

3.  Gnathodiaphyseal dysplasia: Severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5).

Authors:  Ghada A Otaify; Michael P Whyte; Gary S Gottesman; William H McAlister; J Eric Gordon; Abby Hollander; Marisa V Andrews; Samir K El-Mofty; Wei-Shen Chen; Deborah V Veis; Marina Stolina; Albert S Woo; Panagiotis Katsonis; Olivier Lichtarge; Fan Zhang; Marwan Shinawi
Journal:  Bone       Date:  2017-11-21       Impact factor: 4.398

4.  Gnathodiaphyseal dysplasia: report of a family with a novel mutation of the ANO5 gene.

Authors:  Hannah A Duong; Karen T Le; Albert L Soulema; Ronald H Yueh; Maren T Scheuner; Michael F Holick; Russell Christensen; Tracey L Tajima; Angela M Leung; Sanjay M Mallya
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-01-28

5.  The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD).

Authors:  Satoshi Tsutsumi; Nobuyuki Kamata; Tamara J Vokes; Yutaka Maruoka; Koichi Nakakuki; Shoji Enomoto; Ken Omura; Teruo Amagasa; Masaru Nagayama; Fumiko Saito-Ohara; Johji Inazawa; Maki Moritani; Takashi Yamaoka; Hiroshi Inoue; Mitsuo Itakura
Journal:  Am J Hum Genet       Date:  2004-04-29       Impact factor: 11.025

6.  Three novel ANO5 missense mutations in Caucasian and Chinese families and sporadic cases with gnathodiaphyseal dysplasia.

Authors:  Lingling Jin; Yi Liu; Fanyue Sun; Michael T Collins; Keith Blackwell; Albert S Woo; Ernst J Reichenberger; Ying Hu
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

7.  Gnathodiaphyseal dysplasia with a novel genetic variant in a large family from Iran.

Authors:  Vahid Reza Yassaee; Arash Khojasteh; Farzad Hashemi-Gorji; Hossein Sadeghi; Hannaneh Safiaghdam; Reza Mirfakhraie
Journal:  Mol Genet Genomic Med       Date:  2022-06-27       Impact factor: 2.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.